Cells of the immune system that reside in barrier epithelia provide a first line of defense against pathogens. Langerhans cells (LCs) and CD8 + tissue-resident memory T cells (T RM cells) require active transforming growth factor-b1 (TGF-b) for epidermal residence. Here we found that integrins a v b 6 and a v b 8 were expressed in non-overlapping patterns by keratinocytes (KCs) and maintained the epidermal residence of LCs and T RM cells by activating latent TGF-b. Similarly, the residence of dendritic cells and T RM cells in the small intestine epithelium also required a v b 6 . Treatment of the skin with ultraviolet irradiation decreased integrin expression on KCs and reduced the availability of active TGF-b, which resulted in LC migration. Our data demonstrated that regulated activation of TGF-b by stromal cells was able to directly control epithelial residence of cells of the immune system through a novel mechanism of intercellular communication.
The skin is exposed to a wide variety of potential pathogens and commensal microorganisms. Keratinocytes (KCs) that form the stratified squamous epithelium of the epidermis create a physical barrier and also a niche for cells of the immune system that provide an active immunological barrier, notably Langerhans cells (LCs) and CD8 + tissue-resident memory T cells (T RM cells). LCs are a radioresistant, self-renewing subset of dendritic cell (DCs) that reside exclusively in the epidermis 1 . LCs migrate from the epidermis to the skin-draining lymph nodes (LNs), where they present antigen acquired in peripheral tissue to naive and central memory T cells 1 . Migration occurs both homeostatically and in response to microbial or inflammatory cues, including exposure to hapten, ultraviolet (UV) light and skin infection 2, 3 . LCs are required for the induction of responses of the T H 17 subset of helper T cells to specific cutaneous infections and also suppress skin immune responses in a variety of contexts [4] [5] [6] [7] [8] [9] . T RM cells are a subset of memory T cells that maintain long-term residence in barrier tissues 10 . In the skin, CD8 + T RM cells reside in the epidermis and provide protective memory responses to infection with herpes simplex virus or vaccinia virus [11] [12] [13] . They are also thought to mediate autoimmune diseases such as vitiligo and alopecia areata 14, 15 .
Transforming growth factor-β1 (TGF-β) is a pleotropic cytokine that has been long considered an essential growth factor for LCs 16 . However, TGF-β signaling is also required for LCs to maintain their epidermal residence [17] [18] [19] . LCs successfully populate the epidermis in mice with LC-specific genetic ablation of TGF-β receptors (TGF-βRI or TGF-βRII) but spontaneously migrate to skin-draining LNs 17, 18 . Notably, LC-specific ablation of TGF-β induces LC migration, which indicates that autocrine TGF-β is required for the epidermal residence of LCs 17 . The homeostasis of T RM cells also depends on TGF-β. CD8 + T RM cells unable to signal through TGF-β receptors fail to express integrin α E β 7 (CD103) and do not maintain residence in barrier epithelia 20 .
TGF-β is secreted as a biologically inactive complex non-covalently bound to latency-associated peptide (LAP) 21 . Dissociation of LAP from TGF-β can be mediated by the integrins α v β 6 and α v β 8 , which bind to an RGD (Arg-Gly-Asp) sequence in LAP; this allows TGF-β to become biologically active. In vivo, the activation of TGF-β by α v β 6 and α v β 8 in the epidermis is nonredundant 22, 23 .
Here we found that α v β 6 or α v β 8 expressed by KCs was required for the maintenance of epidermal LCs. α v β 6 and α v β 8 were expressed in non-overlapping patterns throughout the epidermis, and ablation or inhibition of α v β 6 or α v β 8 in KCs reduced the availability of active TGF-β, which resulted in loss of LCs from the epidermal region where that integrin was normally expressed. Similarly, residence of DCs in the epithelium of the small intestine and residence of CD8 + T RM cells in both intestinal epithelium and epidermis required α v β 6 . In addition, UV irradiation reduced integrin expression by KCs and diminished the amount of activated TGF-β, which resulted in LC migration that was overcome by constitutive TGF-β signaling in LCs.
Thus, regulated transactivation of LAP-TGF-β by KCs determined the epithelial residence of both DCs and T RM cells.
RESULTS

Epidermal maintenance of LCs in human skin requires TGF-b
To determine whether the epidermal residence of LCs requires TGF-β signaling in human skin, we compared the number of epidermal LCs in skin samples obtained from untreated (control) patients with that in patients treated with losartan. Losartan is an antagonist to the angiotensin II type I receptor commonly used to treat hypertension but also attenuates TGF-β-mediated pathologies by inhibiting TGF-β signaling through an unknown mechanism 24, 25 . The average number of LCs per linear mm of skin was reduced from 21.2 in age-and sexmatched control patients (Supplementary Table 1 ) to 14.3 in losartantreated patients (Fig. 1a and Supplementary Fig. 1) . Thus, the maintenance of LCs in human epidermis seemed to require TGF-β. a v b 6 inhibits homeostatic LC migration by activating TGF-b On the basis of the findings reported above, we hypothesized that homeostatic LC migration would require a loss of TGF-β signaling. To test our hypothesis, we bred huLangerin-CreER T2 mice (which have tamoxifen-inducible expression of Cre recombinase from the LC-specific gene encoding human langerin (huLangerin)) with TGF-βRI-CA mice (which express a loxP-STOP cassette followed by a mutant, constitutively active (CA), hemagglutinin-tagged form of TGF-βRI that signals independently of ligand) to generate TGF-βRI-CA LC mice (with inducible expression of constitutively active TGF-βRI in LCs) 26 . Treatment of TGF-βRI-CA LC mice with tamoxifen efficiently induced the expression of TGF-βRI-CA in LCs without affecting their viability ( Supplementary Fig. 2a,b) . Notably, ligand-independent TGF-β signaling resulted in a normal number of LCs in the epidermis but significantly fewer LCs in the LNs of TGF-βRI-CA LC mice (Fig. 1b,c) , indicative of a failure of homeostatic migration. As a comparison, ablation of TGF-β in LCs produced the opposite phenotype: enhanced migration (Fig. 1b,c) .
Since TGF-β is secreted as a latent complex, we next investigated whether its activation was required for the epidermal maintenance of LCs. Consistent with reports of reduced numbers of LCs in integrin β 6 -deficient (Itgb6 −/− ) mice 22, 23 , we found spontaneous migration of LCs in Itgb6 −/− mice (Fig. 1b,c) . Similarly, in vivo blockade of α v β 6 activity in wild-type mice by intradermal injection of a neutralizing antibody resulted in local reduction in the number of LCs but not that of dermal DCs (Fig. 1d,e and Supplementary Fig. 2c) . Notably, neutralization of α v β 6 in tamoxifen-treated TGF-βRI-CA LC mice did not induce LC migration (Fig. 1d,e) . Similarly, tamoxifen treatment largely restored the epidermal LC network in Itgb6 −/− TGF-βRI-CA LC mice ( Supplementary Fig. 2d,e) . Thus, α v β 6 -mediated activation of TGF-β was needed to maintain LC residence. a v b 6 on interfollicular KCs controls epidermal LC residence Since α v β 6 is expressed by several epithelial tissues, we next investigated whether it was expressed by KCs in the epidermis. We noticed that KCs in wild-type mice expressed α v β 6 , as assessed by immunofluorescence of epidermal mounts, but its expression was not uniform throughout the epidermis (Fig. 2a) . We defined KCs on the basis of their location and relationship to the hair follicle, as interfollicular (IFE), isthmus (IM) and bulge KCs (Supplementary Fig. 3a) . Precursors of LCs are recruited into the epidermis first through the IM before they populate the IFE region but are actively excluded from the bulge area 27 . Using surface markers to identify individual KC Supplementary Fig. 3b ), we noted that α v β 6 expression was evident in the IFE and bulge regions but was absent from the IM (Fig. 2a,b,e) . The residual LCs in Itgb6 −/− mice seemed to 'preferentially' be located in the IM (Fig. 2a) . To confirm that observation, we quantified LCs in the IFE region or IM in wild-type and Itgb6 −/− mice. The number of LCs was significantly lower in the IFE region of Itgb6 −/− mice than in that of wild-type mice but remained unaffected in the IM of Itgb6 −/− mice (Fig. 2c) . In addition, the few LCs that remained in the epidermis of Itgb6 −/− mice were located in close proximity to the hair follicle (Fig. 2d) .
In the epidermis, Itgb6 mRNA expression was higher in IFE KCs than in IM KCs, but Itgb6 mRNA was detectable in LCs (Fig. 2e) . To determine whether maintenance of epidermal LCs relied on expression of α v β 6 by KCs or LCs, we generated bone marrow (BM) chimeras by reconstituting irradiated wild-type(CD45.2 + ) recipient mice or Itgb6 −/− (CD45.2 + ) recipient mice with congenic wild-type (CD45.1 + ) BM cells (wild-type→wild-type mice or wild-type→Itgb6 −/− mice, respectively). A hematopoietic chimerism of >95% was achieved after 6 weeks in blood and LNs ( Supplementary Fig. 4a,b) . As expected, since LC are radio-resistant, they remained of host origin in wild-type mice (Fig. 2f) . In contrast, donor-derived LCs were recruited into the epidermis of wild-type→Itgb6 −/− mice, which resulted in 50% LC chimerism ( Fig. 2f and Supplementary Fig. 4c ). The frequency of host Itgb6 −/− LCs and donor wild-type LCs in the epidermis were equivalent in wild-type→Itgb6 −/− mice ( Fig. 2f and Supplementary Fig. 4c ), which indicated that expression of α v β 6 by LCs was not required for their retention in the epidermis. Instead, the absence of α v β 6 on KCs of wild-type→Itgb6 −/− mice led to a failure of LC precursors to spread beyond the hair follicle, which resulted in the absence of LCs in the IFE region ( Fig. 2g) , similar to that seen in Itgb6 −/− mice. Thus, expression of α v β 6 on IFE KCs controlled the epidermal residence of LC.
Non-overlapping expression of a v b 6 and a v b 8 by KC subsets In addition to α v β 6 , α v β 8 also activates LAP-TGF-β 21 . α v β 8 is expressed by DCs and has a non-redundant role in TGF-β-mediated development of T H 17 cells and regulatory T cells 28, 29 . Expression of α v β 8 by epithelial cells, however, has not been reported, to our knowledge. To investigate whether cells in the epidermis expressed α v β 8 , we compared the expression of α v β 8 -encoding mRNA on sorted populations of epidermal cells. Unexpectedly, we detected minimal expression of Itgb8 (which encodes β 8 ) in LCs (Fig. 3a) . Instead, we found that IM KCs had the highest expression of Itgb8, while IFE KCs had much lower expression of Itgb8 (Fig. 3a) , an expression pattern reciprocal to that seen for Itgb6 (Fig. 2e) . This raised the possibility that the presence of LCs in the IM of Itgb6 −/− mice might have resulted from α v β 8 -mediated activation of TGF-β.
To test that hypothesis, we bred Itgb8 loxP mice (which have loxPflanked Itgb8 alleles) with huLangerin-Cre mice (which express Cre recombinase from the LC-specific gene encoding human langerin) to generate mice with LC-specific ablation of Itgb8 (Itgb8 ∆LC ), or with K14-Cre mice (which express Cre recombinase from the KC-specific gene encoding keratin 14) to generate mice with KC-specific ablation of Itgb8 (Itgb8 ∆KC ). The number of LCs in the epidermis and LNs was unaltered in Itgb8 ∆LC mice relative to that in wild-type mice ( Supplementary Fig. 5a-c) . In contrast, the number of LCs in skindraining LNs was elevated and the number of LCs was decreased in IM of the epidermis of Itgb8 ∆KC mice, relative to that in wildtype mice (Fig. 3b,c) . Notably, the number of LCs was reduced in the IM of the hair follicle but remained unaltered in the IFE region in Itgb8 ∆KC mice, relative to that in wild-type mice, as assessed by immunofluorescence imaging of whole tail mounts and transverse sections of back skin (Fig. 3d,e) . To exclude the possibility that TGF-β might be activated though mechanisms other than those involving npg α v β 6 or α v β 8 , we crossed Itgb8 ∆KC mice with Itgb6 −/− mice. The resulting Itgb8 ∆KC Itgb6 −/− mice lacked expression of both α v β 6 and α v β 8 (data not shown) and were devoid of epidermal LCs (Fig. 3f,g ), which confirmed the absence of compensatory mechanisms for activation of TGF-β in the epidermis. Finally, we directly investigated the necessity for α v β 6 and α v β 8 in the KC-mediated activation of latent TGF-β using an in vitro assay for activated TGF-β 30 . Primary mouse KCs were co-cultured with mink lung reporter cells that had been transfected with a TGF-β-responsive promoter that drives the expression of luciferase. The ability of KCs to activate latent TGF-β was significantly reduced by antibody blockade of α v β 6 in both wild-type cells and Itgb8 ∆KC cells, relative to its activation in their counterparts treated with control antibody (Fig. 3h) . Similarly, the amount of active TGF-β was lower in cultures of KCs derived from Itgb8 ∆KC mice than in cultures of KCs derived from wild-type mice and was further reduced by blockade of α v β 6 (Fig. 3h) . Together these data supported a model in which inactive LAP-TGF-β secreted by LCs is converted into an active form through the action of either α v β 6 or α v β 8 expressed by spatially distinct subsets of KCs, which results in the maintenance of LCs in the epidermis. Intraepithelial DCs expressing integrin α E β 7 (CD103) in the small intestine have been reported 31 . Unlike the skin, the epithelium of the small intestine expressed α v β 6 but not α v β 8 (Supplementary Fig. 6a) . Blockade of α v β 6 via antibody administered weekly for 4 weeks resulted in a reduction in the number of intraepithelial CD103 + DCs, as assessed by immunofluorescence imaging, but did not alter the number of DCs in the lamina propria (Supplementary Fig. 6b-d) . Thus, residence of DCs in both the skin and intestinal barrier surfaces required epithelial α v β 6 .
UV irradiation diminishes TGF-b activation by KCs
In addition to their homeostatic migration, LCs migrate in response to exogenous stimuli such as exposure to UV irradiation 2 . We next sought to determine whether reduced release of TGF-β from LAP by KCs expressing α v β 6 or α v β 8 controlled UV-induced migration. We first exposed the shaved skin of tamoxifen-treated wild-type and TGF-βRI-CA LC mice to UVB at a dose of 100 mJ/cm 2 . After 4 d, we observed a nearly complete absence of LCs, as assessed on the basis of expression of major histocompatibility complex (MHC) class II and langerin, in the epidermis of UVB-treated wild-type mice (Fig. 4a,b) . The few remaining MHCII + cells had very low expression of langerin protein (data not shown), which identified them as short-term monocyte-derived cells and not true, long-term LCs 32 . In contrast, many langerin-positive LCs remained in the epidermis of UVBtreated TGF-βRI-CA LC mice (Fig. 4a,b) . A similar result was obtained by epicutaneous application of the fluorescent hapten TRITC (Supplementary Fig. 7) . Notably, LCs in UVB-treated TGF-βRI-CA LC mice had higher expression of the costimulatory molecule CD86 than that of LCs from their counterparts not treated with UVB, indicative of some degree of activation, but failed to increase their expression of CCR7, the chemokine receptor required for the migration of DCs into draining LNs (Fig. 4c) . Ex vivo KCs from the UVB-irradiated skin of wild-type mice had lower expression of Itgb6 in IFE KCs and of Itgb8 in IM KCs than that of their counterparts from wild-type mice not treated with UVB (Fig. 4d) . Similarly, UVB irradiation reduced the expression of both Itgb6 and Itgb8 in primary cultured wild-type KCs and also reduced the activation of TGF-β by UV irradiation-exposed primary KCs, as measured with luciferase reporter cells (Fig. 4e-g ). Thus, in the setting of UV irradiation, KCs reduced their expression of α v β 6 and α v β 8 , which resulted in smaller amounts of active TGF-β. That in turn led to a failure of LCs to maintain epidermal residence that was overcome by constitutive TGF-β signaling. 20 . CD103 (encoded by Itgae) pairs with integrin β 7 to bind the ligand E-cadherin in various epithelial tissues. TGF-β induces CD103 expression on CD8 + T cells in the small intestine, where CD103 is required for the retention of CD8 + T RM cells in the epithelium but not in the underlying lamina propria [33] [34] [35] . On the basis of those findings and our own observations, we hypothesized that in addition to maintaining the epidermal residence of LCs, the integrin-mediated activation of TGF-β might also be required for the retention of epidermal T RM cells. To test our hypothesis, we adoptively transferred Thy-1.1 + lymphocytic choriomeningitis virus (LCMV)-specific P14 CD8 + T cells into wild-type, Itgb6 −/− , Itgb6 −/− Itgb8 ∆KC or LC-deficient mice, infected the host mice with LCMV (Armstrong strain) and applied the hapten DNFB (an established technique for seeding the epidermis with P14 T cells) topically onto the skin of the host mice 20 . At day 42 after infection, Thy-1.1 + P14 T RM cells were readily detectable in wild-type host mice by immunofluorescence microscopy of epidermal whole mounts (Fig. 5a,b) . In contrast, T RM cells were much less frequent in the epidermis of Itgb6 −/− mice and were completely absent from that of Itgb6 −/− Itgb8 ∆KC mice, despite a normal number of these cells in both blood and LNs of Itgb6 −/− and Itgb6 −/− Itgb8 ∆KC mice (Fig. 5a,b and Supplementary Fig. 8a ). Host mice that lacked LCs had a normal number of T RM cells (Fig. 5a,b and Supplementary Fig. 8a ), which indicated that the retention of T RM cells in the epidermis was independent of LCs, consistent with published reports 36 .
To exclude the possibility that T cells failed to enter the epidermis of Itgb6 −/− and Itgb6 −/− Itgb8 ∆KC mice, rather than persisting there, we first assessed the number of P14 cells using a strategy similar to that described above, except we analyzed mice at day 7 after infection, which coincided with the effector phase of the T cell response. We observed an equivalent number of P14 cells in the skin, blood and LNs of wild-type, Itgb6 −/− and Itgb6 −/− Itgb8 ∆KC host mice (Fig. 5c,d and Supplementary Fig. 8b) . Although P14 cells entered the epidermis in similar numbers in all mice, the frequency of such cells that expressed CD103 was significantly lower in Itgb6 −/− and Itgb6 −/− Itgb8 ∆KC mice than in wild-type mice (Fig. 5e) , consistent with a requirement for active TGF-β for the expression of CD103 by T RM cells 20, 37 . In addition, we treated wild-type recipient mice weekly with neutralizing antibody to α v β 6 for 4 weeks starting 56 d after infection, once T RM cell residence had been established. Neutralization of α v β 6 in wildtype mice efficiently reduced the number of P14 cells in the epidermis but not in the LNs or blood (Fig. 5f,g and Supplementary Fig. 8c) , which demonstrated that the epithelial residence of T RM cells required α v β 6 . Thus, α v β 6 and α v β 8 were required for the development and maintenance of CD8 + T RM cells in epidermis.
Residence of intestine epithelial CD8 + T RM cells requires a v b 6 Since the epithelium of the small intestine expressed α v β 6 and blocking α v β 6 function in vivo led to a reduced number of intraepithelial DCs, we next investigated whether the residence of T RM cells in intestinal epithelium also required α v β 6 . Using an experimental model similar to that described above to generate LCMV-specific T RM cells, we analyzed wild-type and Itgb6 −/− mice host mice at both a memory time point (day 42 after infection) and an effector time points (day 7 after infection) to quantify P14 cells in the epithelium and lamina propria of the small intestine. Consistent with our findings obtained for the epidermis, there was a significantly reduced number of T RM cells, with no difference in the entry of P14 cells, during the effector phase in the intestinal epithelium of Itgb6 −/− mice, compared with that of wild-type mice (Fig. 6a,b,d,e) . The number of P14 cells at the memory and effector phases in intestinal lamina propria was similar in Itgb6 −/− mice and wild-type mice (Fig. 6c,f) . Neutralization of α v β 6 in wildtype mice after T RM cells had been established (day 56 after infection)
efficiently reduced the number of P14 cells in the intestinal epithelium but not in the lamina propria (Fig. 6g-i) , which demonstrated that α v β 6 was required for the maintenance of T RM cells in the epithelium of the small intestine even after T RM cells had been established.
DISCUSSION
Here we have demonstrated that regulated activation of LC-derived LAP-TGF-β by KCs determined whether LCs migrated from the epidermis. We found that KCs expressed α v β 6 and α v β 8 in non Itgb6 
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A r t i c l e s the epidermal region in which that integrin was normally expressed. The migration of LCs in response to UV irradiation required loss of TGF-β signaling in LCs and was accompanied by reduced expression of integrins by KCs. We also found that expression of α v β 6 was required for the persistence of T RM cells in the epidermis and the epithelium of the small intestine. Together these data demonstrate a key role for stromal cells in determining the residence of cells of the immune system within barrier epithelia.
LC migration is thought to result from a combination of LC-intrinsic activation through engagement of pattern-recognition receptors and inflammatory cytokines such as IL-1β and TNF 38 . Our data obtained with TGF-βRI-CA LC mice demonstrated that loss of TGF-β signaling in LCs was required for homeostatic migration and for both UVBinduced migration and hapten-induced migration. Loss of integrin expression by KCs was also sufficient to induce LC migration. Notably, homeostatic and inflammation-induced LC migration is unaffected by the absence of the adaptor MyD88 in LCs 3, 39, 40 . Thus, we speculate that inflammatory mediators known to drive LC migration might act indirectly through KCs and that reduced activation of TGF-β by KCs is a general mechanism that prompts LC migration. Whether KCs modulate integrin expression in the steady state or in response to inflammatory mediators other than those we have tested, however, remains to be determined.
T RM cell differentiation is induced by environmental factors, of which TGF-β remains the best characterized. As with LCs, T RM cells also depended on the transactivation of TGF-β by KCs for epidermal residence. The number of T RM cells was reduced in Itgb6 −/− and Itgb6 −/− Itgb8 ∆KC mice, and antibody blockade of α v β 6 reduced the number of epidermal T RM cells. The recruitment of effector cells into the epidermis was unaffected by the absence of these integrins, but the frequency of cells expressing CD103 was reduced. These results are consistent with a requirement for TGF-β during T RM cell development but also support a model in which tonic exposure to TGF-β, regulated by local TGF-β-activating integrin expression, is constitutively required for their long-term epidermal retention.
Notably, the number of T RM cells was unaffected by the absence of LCs, which indicated that the LCs were not the source of TGF-β that maintained the T RM cells. Dendritic epidermal T cells produced copious amounts of TGF-β (data not shown) but have been reported to remain spatially distinct from T RM cells, so they are unlikely to be critical for the maintenance of T RM cells in the epidermis 36 . KCs are also a major source of TGF-β and probably support epidermal T RM cell residence, although the possibility that TGF-β from T RM cells themselves is involved cannot be excluded. It remains unclear why LCs depend on autocrine TGF-β and do not have access to TGF-β from these other sources.
Epithelial T RM cells in the small intestine require TGF-β for CD103 expression and development 33, 34, 41 . Unlike integrin expression in the epidermis, α v β 6 but not α v β 8 was expressed by epithelial cells in the small intestine, consistent with published findings 42 . The absence of T RM cells in Itgb6 −/− mice and after neutralization of α v β 6 demonstrated that, as in the skin, epithelial T RM cells in the intestine also required α v β 6 for epithelial retention and probably also for their development. Since α v β 6 is widely expressed by many barrier epithelia, T RM cell residence in other tissues might have a similar requirement for this integrin. α v β 8 has been best studied in DCs, in which it provides non-redundant activation of TGF-β and promotes the development of T H 17 cells and regulatory T cells 28, 29 . The unexpected expression of α v β 8 by IM KCs raised the possibility that differential regulation of Itgb6 and Itgb8 by distinct subsets of KCs might allow regional variation in the leukocyte occupancy of the epidermal niche.
A published report has shown that CD103 + DCs are sparsely distributed in intestinal epithelium during steady state and are recruited from the lamina propria in response to infection 31 . It remains unclear whether steady-state CD103 + DCs represent a true population of intraepithelial DCs or a population that continually migrates between the epithelium and lamina propria. We observed fewer epithelial CD103 + DCs than lamina propria CD103 + DCs after inhibition of α v β 6 , which suggested that these cells also depended on continuous TGF-β signaling to maintain CD103 expression, similar to T RM cells; thus, these findings potentially extend our findings to epithelial DCs beyond the epidermis.
In summary, we have defined a novel mechanism of retention of DCs and T RM cells in two barrier epithelia through the regulated activation of TGF-β. Compounds that block TGF-β and inhibit α v β 6 are in clinical trials as cancer therapeutics and to treat fibrosis during lung, liver and kidney diseases 43 . These compounds might have utility in treating diseases in which T RM cells or LCs are pathogenic. In particular, clearing an established population of T RM cells could be especially effective, since they do not circulate and are unlikely to be replenished without the recruitment of additional CD8 + effector cells. In addition, regulated expression of integrins and activation of TGF-β by stromal cells might participate in numerous other TGF-β-mediated processes, including immunological, carcinogenic, tissuerepair, aging and developmental processes. Whether the regulated transactivation of TGF-β we observed in the epidermis and intestinal epithelium occurs in other barrier and non-barrier tissues as well as other contexts remains to be investigated.
METHODS
Methods and any associated references are available in the online version of the paper. 
